244 related articles for article (PubMed ID: 24560097)
21. Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.
Szikora B; Hiripi L; Bender B; Kacskovics I; Iliás A
PLoS One; 2017; 12(9):e0185662. PubMed ID: 28957416
[TBL] [Abstract][Full Text] [Related]
22. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
Thommesen JE; Michaelsen TE; Løset GÅ; Sandlie I; Brekke OH
Mol Immunol; 2000 Nov; 37(16):995-1004. PubMed ID: 11395138
[TBL] [Abstract][Full Text] [Related]
23. Sequence and structural analysis of feline interleukin-5 cDNA.
Padrid PA; Qin Y; Wells TN; Solway J; Camoretti-Mercado B
Am J Vet Res; 1998 Oct; 59(10):1263-9. PubMed ID: 9781459
[TBL] [Abstract][Full Text] [Related]
24. Generation of mutated variants of the human form of the MHC class I-related receptor, FcRn, with increased affinity for mouse immunoglobulin G.
Zhou J; Johnson JE; Ghetie V; Ober RJ; Ward ES
J Mol Biol; 2003 Sep; 332(4):901-13. PubMed ID: 12972260
[TBL] [Abstract][Full Text] [Related]
25. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
Pollastrini J; Dillon TM; Bondarenko P; Chou RY
Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
[TBL] [Abstract][Full Text] [Related]
26. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
[TBL] [Abstract][Full Text] [Related]
27. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
Sandlie I; Aase A; Westby C; Michaelsen TE
Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
[TBL] [Abstract][Full Text] [Related]
28. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
29. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes.
Clark MR; Stuart SG; Kimberly RP; Ory PA; Goldstein IM
Eur J Immunol; 1991 Aug; 21(8):1911-6. PubMed ID: 1831131
[TBL] [Abstract][Full Text] [Related]
30. Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor.
Feng Y; Gong R; Dimitrov DS
Protein Expr Purif; 2011 Sep; 79(1):66-71. PubMed ID: 21453773
[TBL] [Abstract][Full Text] [Related]
31. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
32. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
Canfield SM; Morrison SL
J Exp Med; 1991 Jun; 173(6):1483-91. PubMed ID: 1827828
[TBL] [Abstract][Full Text] [Related]
33. Aspects of the molecular structure of IgG subclasses.
Burton DR; Gregory L; Jefferis R
Monogr Allergy; 1986; 19():7-35. PubMed ID: 2945094
[No Abstract] [Full Text] [Related]
34. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
35. Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases.
Ying T; Feng Y; Wang Y; Chen W; Dimitrov DS
MAbs; 2014; 6(5):1201-10. PubMed ID: 25517305
[TBL] [Abstract][Full Text] [Related]
36. Integrin binding human antibody constant domains--probing the C-terminal structural loops for grafting the RGD motif.
Traxlmayr MW; Wozniak-Knopp G; Antes B; Stadlmayr G; Rüker F; Obinger C
J Biotechnol; 2011 Sep; 155(2):193-202. PubMed ID: 21771617
[TBL] [Abstract][Full Text] [Related]
37. Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.
Arduin E; Arora S; Bamert PR; Kuiper T; Popp S; Geisse S; Grau R; Calzascia T; Zenke G; Kovarik J
Mol Immunol; 2015 Feb; 63(2):456-63. PubMed ID: 25451975
[TBL] [Abstract][Full Text] [Related]
38. Properties of whole human IgG molecules produced by the expression of cloned anti-DNA antibody cDNA in mammalian cells.
Rahman MA; Kettleborough CA; Latchman DS; Isenberg DA
J Autoimmun; 1998 Dec; 11(6):661-9. PubMed ID: 9878088
[TBL] [Abstract][Full Text] [Related]
39. Identification of two allelic IgG1 C(H) coding regions (Cgamma1) of cat.
Kanai TH; Ueda S; Nakamura T
Vet Immunol Immunopathol; 2000 Jan; 73(1):53-62. PubMed ID: 10678398
[TBL] [Abstract][Full Text] [Related]
40. A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha.
Brüggemann M; Teale C; Clark M; Bindon C; Waldmann H
J Immunol; 1989 May; 142(9):3145-50. PubMed ID: 2496159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
